- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Amyloid A4 Antibody reagents are used to investigate amyloid precursor protein (APP) and APP-derived protein species associated with amyloid biology. APP is a type I transmembrane glycoprotein that undergoes extensive proteolytic processing and alternative splicing. Historically, APP and its amyloid-associated products have been described using names including amyloid beta A4 protein, A4, and PreA4, terminology that remains relevant to research examining APP expression and processing.
APP can undergo amyloidogenic or non-amyloidogenic processing. Alpha-secretase cleavage within the amyloid beta region prevents formation of intact amyloid beta peptide, whereas sequential cleavage by beta- and gamma-secretases generates amyloid beta peptides of varying lengths. Amyloid beta 40 and amyloid beta 42 are among the most extensively studied products, with amyloid beta 42 exhibiting a greater tendency to aggregate into oligomers and fibrillar structures.
APP and its cleavage products are investigated in neuronal development, synaptic biology, cell adhesion, protein trafficking, and intracellular signaling. APP belongs to a family that also includes amyloid precursor-like proteins APLP1 and APLP2. Several APP isoforms are generated through alternative splicing, and differences in proteolytic processing further increase the diversity of APP-associated molecular species that may be encountered experimentally.
Amyloid A4 and related APP-derived products are studied extensively in neurodegenerative disease research. Amyloid beta accumulation and plaque formation are characteristic features of Alzheimer disease pathology, while altered APP metabolism is also investigated in relation to neuronal dysfunction and other neurological conditions. An A4 Antibody directed against an APP region can therefore support studies examining the precursor protein and amyloid-associated biology while providing an alternative historical terminology for APP research.
An Amyloid A4 Antibody such as clone APP/9971R provides a monoclonal reagent generated against amino acids 500-700 of human APP. This region encompasses a substantial portion of the APP precursor associated with amyloid processing, rather than representing an immunogen consisting solely of the isolated amyloid beta peptide. NSJ Bioreagents offers APP/9971R for research into APP expression, amyloid-associated processing, and related neuroscience biology.
For a monoclonal targeting the same protein family and amyloid-associated region, see our Amyloid Beta Antibody APP/3345 / Beta Amyloid Antibody page.
Optimal dilution of the Amyloid A4 Antibody APP/9971R / A4 Antibody should be determined by the researcher.
A portion of amino acids 500-700 from human APP protein was used as the immunogen for the Amyloid A4 Antibody APP/9971R.
Aliquot the Amyloid A4 Antibody APP/9971R and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Amyloid A4 antibody, A4 antibody, Amyloid beta A4 protein antibody, APP antibody, Amyloid beta precursor protein antibody, PreA4 antibody, Beta amyloid antibody, ABETA antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.